Stephan T. Stern

Stephan Stern, Ph.D.Stephan T. Stern, PhD, DABT
Sr. Principal Scientist, Pharmacology & Toxicology

Dr. Stern is actively involved in applied nanomaterial research, and has published numerous articles on nanomaterial toxicology and pharmacokinetics in leading scientific journals. In his position at the Nanotechnology Characterization Laboratory (NCL), Dr. Stern is involved in the design and implementation of pharmacology and toxicology studies used to characterize nanoparticle disposition and assess nanoparticle biocompatibility. Data generated is used to support IND regulatory filings and aid in environmental risk assessment. Additional responsibilities include representing NCL at local and national nanotechnology meetings and the education of study personnel regarding nanoparticle safety issues.

Prior to joining the NCL, Dr. Stern was a Post-Doctoral Fellow at the University of North Carolina - Chapel Hill in the Division of Drug Delivery and Disposition, and Curriculum in Toxicology. In this position, his research focused on examining the role of intestinal metabolism in modulating the gastrointestinal toxicity of chemotherapeutic agents. His areas of expertise include biochemical toxicology of the liver and kidney, analytical methodology and drug metabolism/pharmacokinetics. He received his B.S. degree in biochemistry from the University of Rochester and his Ph.D. in toxicology from the University of Connecticut at Storrs. Dr. Stern is a Diplomate of the American Board of Toxicology.